Win Ratio Analysis of the LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

被引：0

作者：

Tobe, Akihiro ^{[1
]}

van Royen, Niels ^{[2
]}

Santos, Ignacio Jesus Amat ^{[3
]}

Hudec, Martin ^{[4
]}

Bunc, Matjaz ^{[5
]}

Ijsselmuiden, Alexander ^{[6
]}

Rosseel, Liesbeth ^{[7
]}

Gamal, Amr ^{[8
]}

McInerney, Angela ^{[9
]}

Garg, Scot ^{[10
]}

Soliman, Osama ^{[1
]}

Onuma, Yoshinobu ^{[11
]}

Baumbach, Andreas ^{[12
]}

Serruys, Patrick ^{[1
]}

机构：

[1] Univ Galway, Galway, Ireland

[2] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands

[3] Univ Clin Hosp Valladolid, Madrid, Spain

[4] SUSCCH, Banska Bystrica, Slovakia

[5] Univ Med Ctr Ljubljana, Ljubljana, Slovenia

[6] Maastricht Univ Med Ctr, Zuyderland Hosp, Maastricht, Netherlands

[7] Algemeen Stedelijk Ziekenhuis, Aalst, Belgium

[8] Blackpool Victoria Hosp, Preston, Lancs, England

[9] Galway Univ Hosp, Dept Cardiol, Saolta Grp, Galway, Ireland

[10] Univ Cent Lancashire, Blackburn, Lancs, England

[11] Natl Univ Ireland Galway, Galway, Ireland

[12] Barts Hlth NHS Trust, Barts Heart Ctr, Dept Cardiol, London, England

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 84卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

TCT-933

引用

页码：B394 / B394

页数：1

共 50 条

[1] Conduction Disturbances and Permanent Pacemaker Implantation After Myval Transcatheter Heart Valve or Contemporary Standard Valves (Sapien and Evolut) Implantation: Insights From the LANDMARK Trial
Smits, Pieter
Rampat, Rajiv
Van Royen, Niels
Amat-Santos, Ignacio
Hudec, Martin
Bunc, Matjaz
Unic, Daniel
Hermanides, Rik
Ninios, Vlasis
Protasiewicz, Marcin
Martin, Pedro
Feres, Fausto
Almeida, Manuel de Sousa
van Belle, Eric
Linke, Axel
Montorfano, Matteo
Webster, Mark
Toutouzas, Konstantinos
Teiger, Emmanuel
Bedogni, Francesco
Voskuil, Michiel
Pan, Manuel
Kim, Won-Keun
Rothe, Jurgen
Kristic, Ivica
Chandra, Udita
Soliman, Osama
Baumbach, Andreas
Tobe, Akihiro
Onuma, Yoshinobu
Serruys, Patrick
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B338 - B339
[2] Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trial
Kawashima, Hideyuki
Soliman, Osama
Wang, Rutao
Ono, Masafumi
Hara, Hironori
Gao, Chao
Zeller, Emeline
Thakkar, Ashokkumar
Tamburino, Corrado
Bedogni, Francesco
Neumann, Franz-Josef
Thiele, Holger
Abdel-Wahab, Mohamed
Morice, Marie-Claude
Webster, Mark
Rosseel, Liesbeth
Mylotte, Darren
Onuma, Yoshinobu
Wijns, William
Baumbach, Andreas
Serruys, Patrick W.
AMERICAN HEART JOURNAL, 2021, 232 : 23 - 38
[3] LANDMARK comparison of early outcomes of newer- generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial
Baumbach, Andreas
van Royen, Niels
Amat-Santos, Ignacio J.
Hudec, Martin
Bunc, Matjaz
Ijsselmuiden, Alexander
Laanmets, Peep
Unic, Daniel
Merkely, Bela
Hermanides, Renicus S.
Ninios, Vlasis
Protasiewicz, Marcin
Rensing, Benno J. W. M.
Martin, Pedro L.
Feres, Fausto
Almeida, Manuel De Sousa
van Belle, Eric
Linke, Axel
Ielasi, Alfonso
Montorfano, Matteo
Webster, Mark
Toutouzas, Konstantinos
Teiger, Emmanuel
Bedogni, Francesco
Voskuil, Michiel
Pan, Manuel
Angeras, Oskar
Kim, Won-Keun
Rothe, Juergen
Kristic, Ivica
Peral, Vicente
Garg, Scot
Elzomor, Hesham
Tobe, Akihiro
Morice, Marie-Claude
Onuma, Yoshinobu
Soliman, Osama
Serruys, Patrick W.
LANCET, 2024, 403 (10445): : 2695 - 2708
[4] Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis
Seth, Ashok
Kumar, Vijay
Singh, Vivudh Pratap
Kumar, Dhananjay
Varma, Puneet
Rastogi, Vishal
INTERVENTIONAL CARDIOLOGY-REVIEWS RESEARCH RESOURCES, 2023, 18
[5] LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial (vol 403, pg 2695, 2024)
Baumbach, A.
van Royen, N.
Amat-Santos, I. J.
LANCET, 2024, 403 (10445): : 2694 - 2694
[6] New-generation Myval transcatheter heart valve in severe aortic stenosis
Akodad, Mariama
Gall, Emmanuel
LANCET, 2024, 403 (10445): : 2664 - 2665
[7] Edwards SAPIEN™ and Edwards SAPIEN XT™ transcatheter heart valves for the treatment of severe aortic stenosis
Freeman, Melanie
Webb, John G.
EXPERT REVIEW OF MEDICAL DEVICES, 2012, 9 (06) : 563 - 569
[8] Transcatheter aortic valve implantation using Evolut PRO versus SAPIEN 3 valves: a randomized comparative trial
Elnaggar, Heba M.
Schoels, Wolfgang
Mahmoud, Marwan S.
Kishk, Yehia T.
Kullmer, Matthias
Dia, Mohamad
Algowhary, Magdy
REC-INTERVENTIONAL CARDIOLOGY, 2023, 5 (02): : 94 - 101
[9] Considering alternatives to transcatheter heart valves for managing patients with severe aortic valve stenosis
Elzomor, Hesham
Elkoumy, Ahmed
Hothi, Sandeep S.
Soliman, Osama
EXPERT REVIEW OF MEDICAL DEVICES, 2024, 21 (1-2) : 109 - 120
[10] The Myval Transcatheter Heart Valve System for the Treatment of Severe Aortic Stenosis - Current Evidence and Future Directions
Sengottuvelu, Gunasekaran
Kumar, Vijay
Seth, Ashok
HEART INTERNATIONAL, 2020, 14 (02): : 86 - 91

← 1 2 3 4 5 →